Skip to main content

Lupus

      Low uptake of SGLT2i in Lupus nephritis
      SGLT2i users had similar adverse event rates as ACEi/ARB users
      SGLT2i users expe
      1 month 2 weeks ago
      Low uptake of SGLT2i in Lupus nephritis SGLT2i users had similar adverse event rates as ACEi/ARB users SGLT2i users experienced more weight loss #ACR24 @rheumnow abst#1534 https://t.co/tB5o7tyhu5
      Study on SLE and NMO overlap:

      Higher risk of acute cystitis & severe sepsis in hospitalized patients
      SLE/NMO overla
      1 month 2 weeks ago
      Study on SLE and NMO overlap: Higher risk of acute cystitis & severe sepsis in hospitalized patients SLE/NMO overlap patients 3x more likely to develop acute cystitis 2x more likely to develop severe sepsis #ACR24 @RheumNow abst#1529
      Study on SLE treatments:
      Compared adverse events of anifrolumab vs. belimumab
      Similar risks for mortality, sepsis, herpe
      1 month 2 weeks ago
      Study on SLE treatments: Compared adverse events of anifrolumab vs. belimumab Similar risks for mortality, sepsis, herpes zoster, dialysis, MACE, PE/VTE, COVID-19, URI, pneumonia, and mental illness #ACR24 @RheumNow abst#1527
      Study on severe lymphopenia in SLE:
      - Assessed incidence, risk factors, and outcomes
      - 11.52% of SLE patients experience
      1 month 2 weeks ago
      Study on severe lymphopenia in SLE: - Assessed incidence, risk factors, and outcomes - 11.52% of SLE patients experienced severe lymphopenia - Higher infection rates during severe lymphopenia period = No opportunistic infections observed #ACR24 abst#1519 @rheumnow @HSSProfEd
      Study on pregnancy outcomes in SLE with thrombocytopenia:

      Higher disease activity, pregnancy loss, and stillbirth rates
      1 month 2 weeks ago
      Study on pregnancy outcomes in SLE with thrombocytopenia: Higher disease activity, pregnancy loss, and stillbirth rates Identified risk factors: Anti-β2GP-I positivity and higher SLEDAI score #ACR24 abst#1487 @RheumNow
      Study on cardiovascular deaths in SLE:
      - Analyzed 1999-2020 data
      - Overall decline in mortality rates, but recent increa
      1 month 2 weeks ago
      Study on cardiovascular deaths in SLE: - Analyzed 1999-2020 data - Overall decline in mortality rates, but recent increase since 2014 - Higher rates in women and African Americans - Geographic disparities noted #ACR24 abst#0998 @rheumnow https://t.co/dpjsl0gI0x
      How do we prevent SLE flares requiring steroids?

      Petri:
      Background medication!
      HCQ adherence is key
      -check WB levels t
      1 month 2 weeks ago
      How do we prevent SLE flares requiring steroids? Petri: Background medication! HCQ adherence is key -check WB levels to measure EULAR recs early addition of immunosuppress/biols “Taper quickly, withdraw slowly” Come down quick, then slowly off @RheumNow #ACR24 @jhrheumatology
      How do you treat a flare of SLE with steroids?

      @RheumNow #ACR24
      1 month 2 weeks ago
      How do you treat a flare of SLE with steroids? @RheumNow #ACR24
      Petri: 5 mg prednisone or less is our standard for lupus control

      EULAR 23 recs - early addition of immunosuppressant an
      1 month 2 weeks ago
      Petri: 5 mg prednisone or less is our standard for lupus control EULAR 23 recs - early addition of immunosuppressant and/or biologics instead to prevent steroids @RheumNow #ACR24 @jhrheumatology https://t.co/jhxEeboPu5
      ×